New radiation approach aims to stop prostate cancer return after surgery
NCT ID NCT03541850
First seen Nov 06, 2025 · Last updated Apr 29, 2026 · Updated 24 times
Summary
This study tests a precise type of radiation called stereotactic body radiotherapy (SBRT) in 92 men whose prostate cancer came back after surgery. The goal is to see if SBRT can control the cancer without causing too many side effects. Participants receive focused radiation over several days to target remaining cancer cells.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE III PROSTATE ADENOCARCINOMA AJCC V7 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California, 90095, United States
-
USC Norris Comprehensive Cancer Center and Hospital
Los Angeles, California, 90033, United States
Conditions
Explore the condition pages connected to this study.